(2026). Utility of inhaled β2-agonists in reducing serum potassium levels in adult patients with hyperkalemia: A scoping review. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Utility of Inhaled β2-agonists in Reducing Serum Potassium Levels in Adult Patients with Hyperkalemia: A Scoping Review."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Utility of Inhaled β2-agonists in Reducing Serum Potassium Levels in Adult Patients with Hyperkalemia: A Scoping Review."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.